Numerous technological advances over the last decade make it possible to modify animal genomes accurately and efficiently.
Recombinetics has developed the knowledge to develop and deploy a multitude of gene editing tools, including TALENs and CRISPRs, to help us intentionally cut the genetic code in the proper place and harness the cell’s DNA repair machinery to introduce the desired change in livestock.
In biomedical and regenerative medicine, our ability to introduce changes in animal DNA opens vast new opportunities to improve and extend human life through novel preclinical products and services aimed at accelerating drug development.
Gene editing in biomedicine allows for more advanced animal models for studying human diseases and for testing and developing safer and more effective therapeutics.
Gene editing used in food animals enables improved animal welfare, lessened use of antibiotics and improved environmental stewardship through lower greenhouse gas outputs and decreased use of natural resources.
Recombinetics deploys gene editing in agriculture and aquaculture through its subsidiary Acceligen.
Acceligen is the world leader in what is often referred to as “precision breeding”, which is a faster, more accurate way to deliver the benefits of crossbreeding. Precision breeding is the next step of the ever-evolving improvement of plants and animals honed over thousands of years of farm animal husbandry.